Solutioning

For brand & commercialization teams

We come prepared, not curious.

Most consultants arrive to learn your business. RxPx arrives having already mapped your molecule, your market, and where programs like yours tend to break down, before the first conversation.

Faster time to treatment
From 6 weeks to 11-16 days
74%
Average PSPs adherence rate
Sustained across MS drug program
90%
Patient satisfaction rating
Across all program types
92%
HCP accounts active
After 1 year in liver monitor program
91%

The execution gap

The program looks right on paper.The real world disagrees.

1 in 3 clinically differentiated launches still fail to meet expectations.* The gap isn’t the science. It’s the decisions made or not made in the 24 months before launch. RxPx embeds with your brand team before the risks are visible, designing the commercialization infrastructure that most programs only try to fix after launch day.

We build onboarding journeys and PSP workflow design.

Strategic advisory

From insights to impact.

RxPx advisory engagements help you make confident decisions early, design the right operational model, and accelerate execution, all without the translation risk of a generalist handoff.

Explore advisory services
Strategic audit
Program health score
82/100
Critical risks
3
Top opportunity
$2.4M
Key finding: Gaps in patient initiation and vendor ecosystem alignment.

Strategic audit

Top-level audit of your program, including where value is being lost, and why. We bring benchmarks and audit tools so you get to insight faster than starting from scratch.

Operational blueprint

Design workshops solving gaps from Phase 1 – safety monitoring, vendor ecosystem, affiliate readiness, governance. Built for your indication, not another industry.

Investment case
Program overview
Economic model
Deployment plan
Ready to proceed

Investment alignment

Translate findings into a structured investment recommendation. We build the case your CFO, medical director, and compliance team each need to say yes.

Solution accelerators

Workshops that drive smarter decisions.

Problem-led sessions designed to solve your most pressing commercialisation challenges. Tangible deliverable every time. Priced to move fast.

Workshop
Format
Deliverables
Patient design thinking
Half-day
Journey map, Drop-off analysis, Adherence redesign
Safe AI integration
Half-day
AI governance framework, Risk map, Integration roadmap
Growth through value
Full day
Journey maps, Growth gap analysis, Engagement strategy
Affiliate & launch readiness
Full day
Readiness report, Operational blueprint, Risk register
Digital GTM best practices
Half-day
GTM framework, Benchmarks, Action plan
Our differentiated approach

Why RxPx.

Operational commercialization expertise. Implementation-ready strategy. The same team that designs your model is the team that builds it.

Generalist consultancies

Strategy without execution depth

Theoretical frameworks

Disconnected handoffs

Slow operational understanding

Limited real-world visibility

Operational commercialization expertise

Implementation-ready strategy

Real-world therapy infrastructure

Safety-grade execution experience

Launch-to-persistence visibility

Proven outcomes

Measurable impact across the commercialization journey.

66%

Reduction in FTE hours required
for lab coordination

96%

Adherence in trials

92%

Adherence in real world settings

50%

HCPs voluntarily enrolled in first 12 months

Based on RxPx safety monitoring data.

The execution gap

Shape the brief
before it’s written.

The brand managers who get the best outcomes engage RxPx before the budget is set. That’s when we can do the most. Start with a workshop. Fast to approve. Real output from day one.

See how it works

*ZS Associates, 2025 — study of 340 drug launches.